These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A rationale for dopamine agonists as primary therapy for Parkinson's disease. Olanow CW Can J Neurol Sci; 1992 Feb; 19(1 Suppl):108-12. PubMed ID: 1349262 [TBL] [Abstract][Full Text] [Related]
24. Dietary factors in the management of Parkinson's disease. Kempster PA; Wahlqvist ML Nutr Rev; 1994 Feb; 52(2 Pt 1):51-8. PubMed ID: 8183469 [TBL] [Abstract][Full Text] [Related]
25. Original research: The perioperative experience of patients with Parkinson's disease: a qualitative study. Anderson LC; Fagerlund K Am J Nurs; 2013 Feb; 113(2):26-32; quiz 33. PubMed ID: 23334560 [TBL] [Abstract][Full Text] [Related]
26. The treatment of Parkinson's disease: current concepts and rationale. Hingtgen CM; Siemers E Compr Ther; 1998; 24(11-12):560-6. PubMed ID: 9847972 [TBL] [Abstract][Full Text] [Related]
27. Parkinson's syndrome. Recent progress in the medical treatment and its pharmacological basis. Shibasaki H Minn Med; 1971 Oct; 54(10):839-49. PubMed ID: 4398771 [No Abstract] [Full Text] [Related]
30. [The dopamine agonist, lisuride, in the therapy of Parkinson disease]. Madeja UD Acta Histochem Suppl; 1992; 42():25-31. PubMed ID: 1584973 [TBL] [Abstract][Full Text] [Related]
31. [Nursing process: nursing of patients with Parkinson's disease. Nursing before and after withdrawal for the purpose of medication control of patients with Parkinson's disease]. Kanagawa M; Osaga W; Ishii T; Saika M; Ishii T Kurinikaru Sutadi; 1985 Aug; 6(8):933-9. PubMed ID: 3850295 [No Abstract] [Full Text] [Related]
33. A community survey of Parkinson's disease. Snow B; Wiens M; Hertzman C; Calne D CMAJ; 1989 Sep; 141(5):418-22. PubMed ID: 2766181 [TBL] [Abstract][Full Text] [Related]
34. Drug management of Parkinson's disease. Kishore A; Snow BJ Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697 [TBL] [Abstract][Full Text] [Related]
35. [Recent advances and pharmacological basis of the medical treatment of Parkinson's syndrome]. Shibazaki H Shinkei Kenkyu No Shimpo; 1971; 15(4):992-1002. PubMed ID: 4400830 [No Abstract] [Full Text] [Related]
36. [Biochemical basis for using selective monoamine oxidase inhibitors in the treatment of Parkinson's disease. Critical contribution]. Amato L; Nava L; Rizzo M; Piccoli F Riv Neurol; 1985; 55(1):46-52. PubMed ID: 3927468 [No Abstract] [Full Text] [Related]
37. NMDA antagonists as Parkinson's disease therapy: disseminating the evidence. Majláth Z; Vécsei L Neurodegener Dis Manag; 2014; 4(1):23-30. PubMed ID: 24640976 [TBL] [Abstract][Full Text] [Related]
38. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment. Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092 [TBL] [Abstract][Full Text] [Related]
39. [Progress in the treatment of Parkinson's disease]. Nakamura S Nihon Naika Gakkai Zasshi; 1999 Mar; 88(3):465-9. PubMed ID: 10341623 [No Abstract] [Full Text] [Related]
40. Current approaches in the treatment of Parkinson's disease. Stacy M; Jankovic J Annu Rev Med; 1993; 44():431-40. PubMed ID: 8476262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]